UCL School of Pharmacy
- Current Students
- Pharmacy News Publication
- Pharmacy Events Publication
- Behavioural medicine and treatment optimisation events
- Biodiversity and medicines events
- Disease models and clinical pharmacology events
- Drug discovery events
- Global workforce and education events
- Molecular drug delivery and nanomedicine events
- Neuroscience in health & disease events
- Pharmaceutical materials and dosage form design events
Professor Simon Gibbons, a member of the Advisory Council on the Misuse of Drugs, has recommended a broader drugs education in primary and middle schools. At present, there is little coverage of this issue in the curriculum and Prof Gibbons argues that awareness of these matters should be raised from an early age. To find out more, read his interview in the Daily Telegraph.
BioKier Inc has entered into an exclusive license agreement with UCL Business PLC (UCLB) for the proprietary colon delivery technology (PhloralTM) developed by researchers at the UCL School of Pharmacy. PhloralTM will be used in the formulation of an anti-diabetes drug, BKR-013, under development by BioKier Inc.
Professor Rob Horne was a co-applicant on a successful
£2 million bid to establish the Asthma UK
Centre for Applied Research (AUK CAR). The BMTO research cluster was one of 13 leading academic research
organisations from across the UK comprising a successful bid for £2 million to
establish the AUK CAR.
UCL School of Pharmacy has created a new Research Innovation Fund (RIF) that will provide funding for early-stage pilot projects of timeliness and promise. The objectives of the scheme are: i) to increase the availability of specialised equipment and essential consumable materials and ii) to stimulate cross-disciplinary research that will lead to future grant applications to the BBSRC, EPSRC, MRC or EU. More...